참고문헌
- Adam, R.C., Yang, H., Rockowitz, S., Larsen, S.B., Nikolova, M., Oristian, D.S., Polak, L., Kadaja, M., Asare, A., Zheng, D., et al. (2015). Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521, 366-370. https://doi.org/10.1038/nature14289
- Affer, M., Chesi, M., Chen, W.D., Keats, J.J., Demchenko, Y.N., Tamizhmani, K., Garbitt, V.M., Riggs, D.L., Brents, L.A., Roschke, A.V., et al. (2014). Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia 28, 1725-1735. https://doi.org/10.1038/leu.2014.70
- Andersson, R. (2015). Promoter or enhancer, what's the difference? Deconstruction of established distinctions and presentation of a unifying model. Bioessays 37, 314-323. https://doi.org/10.1002/bies.201400162
- Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., et al. (2014). An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461. https://doi.org/10.1038/nature12787
- Beagrie, R.A. and Pombo, A. (2016). Gene activation by metazoan enhancers: Diverse mechanisms stimulate distinct steps of transcription. Bioessays 38, 881-893. https://doi.org/10.1002/bies.201600032
- Chapuy, B., McKeown, M.R., Lin, C.Y., Monti, S., Roemer, M.G., Qi, J., Rahl, P.B., Sun, H.H., Yeda, K.T., Doench, J.G., et al. (2013). Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24, 777-790. https://doi.org/10.1016/j.ccr.2013.11.003
- Cheng, J.H., Pan, D.Z., Tsai, Z.T., and Tsai, H.K. (2015). Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues. Sci. Rep. 5, 12648. https://doi.org/10.1038/srep12648
- Christensen, C.L., Kwiatkowski, N., Abraham, B.J., Carretero, J., Al- Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G.S., Akbay, E.A., Altabef, A., et al. (2014). Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26, 909-922. https://doi.org/10.1016/j.ccell.2014.10.019
- Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al. (2010). Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107, 21931-21936. https://doi.org/10.1073/pnas.1016071107
- Dang, C.V. (2012). MYC on the path to cancer. Cell 149, 22-35. https://doi.org/10.1016/j.cell.2012.03.003
- Felsher, D.W., Zetterberg, A., Zhu, J., Tlsty, T., and Bishop, J.M. (2000). Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc. Natl. Acad. Sci. USA 97, 10544-10548. https://doi.org/10.1073/pnas.190327097
- Gabay, M., Li, Y., and Felsher, D.W. (2014). MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb. Perspect. Med. 4, pii: a014241.
- Gosselin, D., Link, V.M., Romanoski, C.E., Fonseca, G.J., Eichenfield, D.Z., Spann, N.J., Stender, J.D., Chun, H.B., Garner, H., Geissmann, F., et al. (2014). Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327-1340. https://doi.org/10.1016/j.cell.2014.11.023
- Hah, N., Murakami, S., Nagari, A., Danko, C.G., and Kraus, W.L. (2013). Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 23, 1210-1223. https://doi.org/10.1101/gr.152306.112
- Hah, N., Benner, C., Chong, L.W., Yu, R.T., Downes, M., Evans, R.M. (2015). Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc. Natl. Acad. Sci. USA 112, E297-302. https://doi.org/10.1073/pnas.1424028112
- Heintzman, N.D., Murakami, S., Nagari, A., Danko, C.G., and Kraus, W.L. (2009). Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112. https://doi.org/10.1038/nature07829
- Herranz, D., Ambesi-Impiombato, A., Palomero, T., Schnell, S.A., Belver, L., Wendorff, A.A., Xu, L., Castillo-Martin, M., Llobet-Navas, D., Cordon-Cardo, C., et al. (2014). A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat. Med. 20, 1130-1137. https://doi.org/10.1038/nm.3665
- Heyn, H., Vidal, E., Ferreira, H.J., Vizoso, M., Sayols, S., Gomez, A., Moran, S., Boque-Sastre, R., Guil, S., Martinez-Cardus, A., et al. (2016). Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biol. 17, 11. https://doi.org/10.1186/s13059-016-0879-2
- Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V., Sigova, A.A., Hoke, H.A., and Young, R.A. (2013). Super-enhancers in the control of cell identity and disease. Cell 155, 934-947. https://doi.org/10.1016/j.cell.2013.09.053
- Hnisz, D., Schuijers, J., Lin, C.Y., Weintraub, A.S., Abraham, B.J., Lee, T.I., Bradner, J.E., and Young, R.A. (2015). Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol. Cell 58, 362-370. https://doi.org/10.1016/j.molcel.2015.02.014
- Hon, G.C., Hawkins, R.D. and Ren, B. (2009). Predictive chromatin signatures in the mammalian genome. Hum. Mol. Genet. 18, R195- 201. https://doi.org/10.1093/hmg/ddp409
- Hsieh, A.L., Walton, Z.E., Altman, B.J., Stine, Z.E., and Dang, C.V. (2015). MYC and metabolism on the path to cancer. Semin. Cell Dev. Biol. 43, 11-21. https://doi.org/10.1016/j.semcdb.2015.08.003
- Huang, J., Liu, X., Li, D., Shao, Z., Cao, H., Zhang, Y., Trompouki, E., Bowman, T.V., Zon, L.I., Yuan, G.C., et al. (2016). Dynamic control of enhancer repertoires drives lineage and stage-specific transcription during hematopoiesis. Dev. Cell 36, 9-23. https://doi.org/10.1016/j.devcel.2015.12.014
- Jiang, Y.Y., Lin, D.C., Mayakonda, A., Hazawa, M., Ding, L.W., Chien, W.W., Xu, L., Chen, Y., Xiao, J.F., Senapedis, W., et al. (2016). Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Gut pii: gutjnl-2016-311818.
- Kaikkonen, M.U., Lin, D.C., Mayakonda, A., Hazawa, M., Ding, L.W., Chien, W.W., Xu, L., Chen, Y., Xiao, J.F., Senapedis, W., et al. (2013). Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 51, 310-325. https://doi.org/10.1016/j.molcel.2013.07.010
- Kim, T.K., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin, D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010). Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187. https://doi.org/10.1038/nature09033
- King, A.D., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin, D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2016). Reversible regulation of promoter and enhancer histone landscape by DNA methylation in mouse embryonic stem cells. Cell Rep. 17, 289-302. https://doi.org/10.1016/j.celrep.2016.08.083
- Kitagawa, Y., Ohkura, N., Kidani, Y., Vandenbon, A., Hirota, K., Kawakami, R., Yasuda, K., Motooka, D., Nakamura, S., Kondo, M., et al. (2017). Guidance of regulatory T cell development by Satb1- dependent super-enhancer establishment. Nat. Immunol. 18, 173-183.
- Kron, K.J., Bailey, S.D., and Lupien, M. (2014). Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med. 6, 77. https://doi.org/10.1186/s13073-014-0077-3
- Lam, M.T., Li, W., Rosenfeld, M.G., and Glass, C.K. (2014). Enhancer RNAs and regulated transcriptional programs. Trends Biochem. Sci. 39, 170-182. https://doi.org/10.1016/j.tibs.2014.02.007
- Landen, C.N., Jr., Goodman, B., Katre, A.A., Steg, A.D., Nick, A.M., Stone, R.L., Miller, L.D., Mejia, P.V., Jennings, N.B., Gershenson, D.M., et al. (2010). Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol. Cancer Ther. 9, 3186-3199. https://doi.org/10.1158/1535-7163.MCT-10-0563
- Le Noir, S., Laffleur, B., Carrion, C., Garot, A., Lecardeur, S., Pinaud, E., Denizot, Y., Skok, J., and Cogne, M. (2017). The IgH locus 3' cisregulatory super-enhancer co-opts AID for allelic transvection. Oncotarget [Epub ahead of print]
- Leveille, N., Melo, C.A., Rooijers, K., Diaz-Lagares, A., Melo, S.A., Korkmaz, G., Lopes, R., Akbari Moqadam, F., Maia, A.R., Wijchers, P.J., et al. (2015). Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat. Commun. 6, 6520. https://doi.org/10.1038/ncomms7520
- Li, W., Notani, D., Ma, Q., Tanasa, B., Nunez, E., Chen, A.Y., Merkurjev, D., Zhang, J., Ohgi, K., Song, X., et al. (2013). Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498, 516-520. https://doi.org/10.1038/nature12210
- Li, W., Hu, Y., Oh, S., Ma, Q., Merkurjev, D., Song, X., Zhou, X., Liu, Z., Tanasa, B., He, X., et al. (2015). Condensin I and II complexes license full estrogen receptor alpha-dependent enhancer activation. Mol. Cell 59, 188-202. https://doi.org/10.1016/j.molcel.2015.06.002
- Li, W., Notani, D., and Rosenfeld, M.G. (2016). Enhancers as noncoding RNA transcription units: recent insights and future perspectives. Nat. Rev. Genet. 17, 207-223. https://doi.org/10.1038/nrg.2016.4
- Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K.M., Kieff, E., and Zhao, B. (2016). Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc. Natl. Acad. Sci. USA 113, 14121-14126. https://doi.org/10.1073/pnas.1616697113
- Liu, C.F., and Lefebvre, V. (2015). The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis. Nucleic Acids Res. 43, 8183-8203. https://doi.org/10.1093/nar/gkv688
- Loven, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I., and Young, R.A. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320-334. https://doi.org/10.1016/j.cell.2013.03.036
- Mansour, M.R., Abraham, B.J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A.D., Etchin, J., Lawton, L., Sallan, S.E., Silverman, L.B., et al. (2014). Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346, 1373-1377. https://doi.org/10.1126/science.1259037
- Mattick, J.S. and Makunin, I.V. (2006). Non-coding RNA. Hum. Mol. Genet. 15 Spec. No 1, R17-29.
- Mousavi, K., Zare, H., Dell'orso, S., Grontved, L., Gutierrez-Cruz, G., Derfoul, A., Hager, G.L., and Sartorelli, V. (2013). eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol. Cell 51, 606-617. https://doi.org/10.1016/j.molcel.2013.07.022
- Murakawa, Y., Yoshihara, M., Kawaji, H., Nishikawa, M., Zayed, H., Suzuki, H., Fantom, Consortium., and Hayashizaki, Y. (2016). Enhanced identification of transcriptional enhancers provides mechanistic insights into diseases. Trends Genet. 32, 76-88. https://doi.org/10.1016/j.tig.2015.11.004
- Niederriter, A.R., Varshney, A., Parker, S.C., and Martin, D.M. (2015). Super enhancers in cancers, complex disease, and developmental disorders. Genes (Basel) 6, 1183-1200. https://doi.org/10.3390/genes6041183
- Ohba, S., He, X., Hojo, H., and McMahon, A.P. (2015). Distinct transcriptional programs underlie Sox9 regulation of the mammalian chondrocyte. Cell Rep. 12, 229-243. https://doi.org/10.1016/j.celrep.2015.06.013
- Pedersen, N., Mortensen, S., Sorensen, S.B., Pedersen, M.W., Rieneck, K., Bovin, L.F., and Poulsen, H.S. (2003). Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res. 63, 1943-1953.
- Pefanis, E., Wang, J., Rothschild, G., Lim, J., Kazadi, D., Sun, J., Federation, A., Chao, J., Elliott, O., Liu, Z.P., et al. (2015). RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell 161, 774-789. https://doi.org/10.1016/j.cell.2015.04.034
- Pelish, H.E., Liau, B.B., Nitulescu, I.I., Tangpeerachaikul, A., Poss, Z.C., Da Silva, D.H., Caruso, B.T., Arefolov, A., Fadeyi, O., Christie, A.L., et al. (2015). Mediator kinase inhibition further activates superenhancer- associated genes in AML. Nature 526, 273-276. https://doi.org/10.1038/nature14904
- Pnueli, L., Rudnizky, S., Yosefzon, Y., and Melamed, P. (2015). RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin alpha-subunit gene. Proc. Natl. Acad. Sci. USA 112, 4369-4374. https://doi.org/10.1073/pnas.1414841112
- Pott, S,. and Lieb, J.D. (2015). What are super-enhancers? Nat. Genet. 47, 8-12. https://doi.org/10.1038/ng.3167
- Qian, J., Wang, Q., Dose, M., Pruett, N., Kieffer-Kwon, K.R., Resch, W., Liang, G., Tang, Z., Mathe, E., Benne,r C., et al. (2014). B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159, 1524-1537. https://doi.org/10.1016/j.cell.2014.11.013
- Schaukowitch, K., Joo, J.Y., Liu, X., Watts, J.K., Martinez, C., and Kim, T.K. (2014). Enhancer RNA facilitates NELF release from immediate early genes. Mol. Cell 56, 29-42. https://doi.org/10.1016/j.molcel.2014.08.023
- Schmidt, S.F., Larsen, B.D., Loft, A., Nielsen, R., Madsen, J.G., and Mandrup, S. (2015). Acute TNF-induced repression of cell identity genes is mediated by NFkappaB-directed redistribution of cofactors from super-enhancers. Genome Res. 25, 1281-1294. https://doi.org/10.1101/gr.188300.114
- Shibayama, Y., Fanucchi, S., Magagula, L., and Mhlanga, M.M. (2014). lncRNA and gene looping: what's the connection? Transcription 5, e28658. https://doi.org/10.4161/trns.28658
- Shin, H.Y., Willi, M., Yoo, K.H., Zeng, X., Wang, C., Metser, G., and Hennighausen, L. (2016). Hierarchy within the mammary STAT5- driven Wap super-enhancer. Nat. Genet. 48, 904-911. https://doi.org/10.1038/ng.3606
- Shlyueva, D., Stampfel, G., and Stark, A. (2014). Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286. https://doi.org/10.1038/nrg3682
- Shou, Y., Martelli, M.L., Gabrea, A., Qi, Y., Brents, L.A., Roschke, A., Dewald, G., Kirsch, I.R., Bergsagel, P.L., and Kuehl, W.M. (2000). Diverse karyotypic abnormalities of the c-myc locus associated with cmyc dysregulation and tumor progression in multiple myeloma. Proc. Natl. Acad. Sci. USA 97, 228-233. https://doi.org/10.1073/pnas.97.1.228
- Siersbaek, R., Rabiee, A., Nielsen, R., Sidoli, S., Traynor, S., Loft, A., La Cour Poulsen, L., Rogowska-Wrzesinska, A., Jensen, O.N., and Mandrup, S. (2014). Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep. 7, 1443-1455. https://doi.org/10.1016/j.celrep.2014.04.042
- Steg, A.D., Bevis, K.S., Katre, A.A., Ziebarth, A., Dobbin, Z.C., Alvarez, R.D., Zhang, K., Conner, M., and Landen, C.N. (2012). Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin. Cancer Res. 18, 869-881. https://doi.org/10.1158/1078-0432.CCR-11-2188
- Teppo, S., Laukkanen, S., Liuksiala, T., Nordlund, J., Oittinen, M., Teittinen, K., Gronroos, T., St-Onge, P., Sinnett, D., Syvanen, A.C., et al. (2016). Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia. Genome Res. 26, 1468-1477. https://doi.org/10.1101/gr.193649.115
- Vahedi, G., Laukkanen, S., Liuksiala, T., Nordlund, J., Oittinen, M., Teittinen, K., Gronroos, T., St-Onge, P., Sinnett, D., Syvanen, A.C., et al. (2015). Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520, 558-562. https://doi.org/10.1038/nature14154
- van der Steen, T., Tindall, D.J., and Huang, H. (2013). Posttranslational modification of the androgen receptor in prostate cancer. Int. J. Mol. Sci. 14, 14833-14859. https://doi.org/10.3390/ijms140714833
- Wei, Y., Zhang, S., Shang, S., Zhang, B., Li, S., Wang, X., Wang, F., Su, J., Wu, Q., Liu, H., et al. (2016). SEA: a super-enhancer archive. Nucleic Acids Res. 44, D172-179. https://doi.org/10.1093/nar/gkv1243
- Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I., Young, R.A. (2013). Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319. https://doi.org/10.1016/j.cell.2013.03.035
- Willi, M., Yoo, K.H., Wang, C., Trajanoski, Z., and Hennighausen, L. (2016). Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation. Nucleic Acids Res. 44, 10277-10291.
- Wu, H., Nord, A.S., Akiyama, J.A., Shoukry, M., Afzal, V., Rubin, E.M., Pennacchio, L.A., and Visel, A. (2014). Tissue-specific RNA expression marks distant-acting developmental enhancers. PLoS Genet. 10, e1004610. https://doi.org/10.1371/journal.pgen.1004610
- Yokoyama, Y., Zhu, H., Lee, J.H., Kossenkov, A.V., Wu, S.Y., Wickramasinghe, J.M., Yin, X., Palozola, K.C., Gardini, A., Showe, L.C., et al. (2016). BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer. Cancer Res. 76, 6320- 6330. https://doi.org/10.1158/0008-5472.CAN-16-0854
- Zhang, S., Li, Y., Wu, Y., Shi, K., Bing, L., and Hao, J. (2012). Wnt/beta-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells. Anat. Rec. (Hoboken) 295, 2104-2113. https://doi.org/10.1002/ar.22592
- Zhao, J., Zhao, Y., Wang, L., Zhang, J., Karnes, R.J., Kohli, M., Wang, G., and Huang, H. (2016). Alterations of androgen receptorregulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer. Oncotarget 7, 38551-38565. https://doi.org/10.18632/oncotarget.9535
- Zhao, Y., Wang, L., Ren, S., Wang, L., Blackburn, P.R., McNulty, M.S., Gao, X., Qiao, M., Vessella, R.L., Kohli, M., et al. (2016). Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in castrationresistant prostate cancer. Cell Rep. 15, 599-610. https://doi.org/10.1016/j.celrep.2016.03.038
피인용 문헌
- Targeting Transcription Factors for Cancer Treatment vol.23, pp.6, 2018, https://doi.org/10.3390/molecules23061479
- Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer vol.19, pp.2, 2017, https://doi.org/10.3390/ijms19020570
- Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic Cancer vol.2, pp.2, 2018, https://doi.org/10.3390/epigenomes2020008
- Targeting Super-Enhancers for Disease Treatment and Diagnosis vol.41, pp.6, 2017, https://doi.org/10.14348/molcells.2018.2297
- Enhancer and super‐enhancer: Positive regulators in gene transcription vol.1, pp.3, 2018, https://doi.org/10.1002/ame2.12032
- Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases vol.4, pp.2, 2017, https://doi.org/10.1136/rmdopen-2018-000744
- Dissecting super-enhancer hierarchy based on chromatin interactions vol.9, pp.1, 2017, https://doi.org/10.1038/s41467-018-03279-9
- BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer vol.41, pp.12, 2017, https://doi.org/10.14348/molcells.2018.0425
- Super-Enhancer-Associated Hub Genes In Chronic Myeloid Leukemia Identified Using Weighted Gene Co-Expression Network Analysis vol.11, pp.None, 2017, https://doi.org/10.2147/cmar.s214614
- MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer vol.120, pp.6, 2019, https://doi.org/10.1038/s41416-019-0395-8
- The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma vol.1, pp.1, 2017, https://doi.org/10.1093/noajnl/vdz023
- Dysregulated Transcriptional Control in Prostate Cancer vol.20, pp.12, 2019, https://doi.org/10.3390/ijms20122883
- A distal super enhancer mediates estrogen-dependent mouse uterine–specific gene transcription of Igf1 (insulin-like growth factor 1) vol.294, pp.25, 2019, https://doi.org/10.1074/jbc.ra119.008759
- Retroelement-Linked H3K4me1 Histone Tags Uncover Regulatory Evolution Trends of Gene Enhancers and Feature Quickly Evolving Molecular Processes in Human Physiology vol.8, pp.10, 2019, https://doi.org/10.3390/cells8101219
- The anti-cancer drugs curaxins target spatial genome organization vol.10, pp.1, 2017, https://doi.org/10.1038/s41467-019-09500-7
- Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation vol.20, pp.suppl10, 2017, https://doi.org/10.1186/s12864-019-6293-x
- Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs vol.21, pp.10, 2020, https://doi.org/10.3390/ijms21103711
- Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer vol.39, pp.42, 2017, https://doi.org/10.1038/s41388-020-01456-z
- ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation vol.33, pp.6, 2017, https://doi.org/10.1016/j.celrep.2020.108366
- Ontology-driven integrative analysis of omics data through Onassis vol.10, pp.None, 2017, https://doi.org/10.1038/s41598-020-57716-1
- Polymorphic mobile element insertions contribute to gene expression and alternative splicing in human tissues vol.21, pp.1, 2017, https://doi.org/10.1186/s13059-020-02101-4
- Mapping cis-regulatory elements in the midgestation mouse placenta vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-01664-x